Alexander Fleming and the Discovery of Penicillin

Alexander Fleming was a Scottish physician who accidentally discovered penicillin in 1928 when he noticed a mold killing bacteria in his lab. But that's not the whole story. He'd already discovered lysozyme in 1921, an antibacterial enzyme he believed would outshine penicillin. It took over a decade before Florey and Chain transformed his observation into a life-saving drug. There's far more to Fleming's story than most people ever learn.

Key Takeaways

• Fleming was born in rural Ayrshire, Scotland in 1881 and won the gold medal as London University's top medical student in 1908.
• Before penicillin, Fleming discovered lysozyme in 1921, a natural antibacterial enzyme found in tears, saliva, and nasal mucus.
• Fleming noticed penicillin accidentally in 1928 when a rare mold contaminated a petri dish, creating a bacteria-killing zone.
• Penicillin works by targeting bacterial cell walls, inhibiting enzymes that maintain structure, causing bacteria to rupture and die.
• A moldy cantaloupe discovered by Mary Hunt produced 200 times more penicillin than Fleming's original mold, enabling mass production.

Who Was Alexander Fleming Before Penicillin?

Before becoming the scientist who changed medicine forever, Alexander Fleming lived a far humbler life on Lochfield farm in rural Ayrshire, Scotland, where he was born on August 6, 1881. He was the third of four children from his father's second marriage and moved to London at 13 to pursue education and opportunity.

His path led him to St. Mary's Hospital Medical School, where his pre-penicillin bacteriology pursuits took shape under immunology pioneer Sir Almroth Wright. Fleming's military medical experiences during World War I proved equally formative — serving as a captain, he witnessed antiseptics failing against deep wound infections, even worsening tissue damage. Those observations sharpened his resolve to find more effective antibacterial solutions, ultimately setting the stage for his groundbreaking discovery. He attended Kilmarnock Academy before enrolling at St. Mary's Hospital Medical School in Paddington in 1903.

A brilliant and dedicated student, Fleming was awarded the 1908 gold medal as the top medical student at the University of London, a distinction that foreshadowed the remarkable scientific contributions he would make throughout his career.

The Lysozyme Discovery Most People Have Never Heard Of

Fleming's wartime frustration with failing antiseptics didn't just lead him to penicillin — it first led him to something most people have never heard of. In late 1921, his nasal mucus accidentally dropped onto a bacteria-covered agar plate. Within minutes, a clear killing zone appeared. He tested tears, saliva, blood, and egg white — all contained the same bactericidal agent. He named it lysozyme, marking a genuine biomedical novelty as the first enzyme discovered with antibacterial properties.

Yet you'd rarely see it mentioned alongside penicillin. Peers dismissed it as irrelevant, a classic case of medical oversight. Fleming himself insisted until 1955 that lysozyme would eventually outshine penicillin in significance. Seven years before his famous mold discovery, he'd already changed immunological research forever. Today, lysozyme is recognized across 27,633 scientific articles, reflecting the profound and lasting impact of a discovery once brushed aside as a curiosity. Fleming shared the 1945 Nobel Prize in Physiology or Medicine with Ernst Boris Chain and Sir Howard Walter Florey for his work in discovering penicillin and its curative effect in infectious diseases.

The Accidental Discovery That Changed Medicine

Most people know the broad outline: a messy lab, a forgotten petri dish, a lucky mold.

But the details reveal something richer. Returning from holiday on September 3, 1928, Fleming noticed a clear zone surrounding a contaminant mold in his Staphylococcus dish. That mold, a rare Penicillium notatum strain, was secreting something lethal to nearby bacteria.

Fleming named the substance penicillin and published his findings in June 1929, noting unexpected therapeutic applications almost in passing. Few listened.

The road to penicillin production stalled for a decade, largely because purifying the unstable substance proved nearly impossible. It took Florey and Chain's Oxford work in 1939-1940, followed by wartime mass production, to transform Fleming's accidental observation into medicine's most consequential breakthrough. A Penicillium mould sample was even gifted to a colleague at St. Mary's Hospital, London, in 1935, keeping the discovery alive during those quiet years.

Chain, Florey, and Fleming were awarded the 1945 Nobel Prize in Physiology or Medicine, a recognition that cemented penicillin's place as one of the most transformative discoveries in the history of medicine.

What Fleming Actually Said When He Saw the Mold?

One of history's most celebrated scientific moments has no verified dramatic quote attached to it. When Fleming returned from holiday on September 3, 1928, and noticed the mold's effect on his staphylococci cultures, history records no immediate reaction description. No exclamation, no dramatic declaration — just quiet contemplation followed by deliberate action.

What Fleming actually did speaks louder than any missing quote. He preserved the contaminated plate, subcultured the mold in a broth tube, and immediately began testing its properties. His 1929 paper reveals his mindset more accurately than invented phrases could — he recognized something extraordinary, coined the term penicillin, and methodically documented its antibacterial specificity. His prior work with lysozyme had sharpened his instincts, letting him act decisively where others might've discarded the plate entirely. Fleming published his findings in the British Journal of Experimental Pathology in 1929, formally introducing the scientific community to the antibiotic potential of what he had identified as Penicillium notatum.

Despite Fleming's foundational discovery, it was the later work of scientists like Mary Hunt — whose discovery of a moldy cantaloupe in Peoria produced 200 times more penicillin than Fleming's original mold — that transformed penicillin from a laboratory curiosity into a life-saving drug produced at an industrial scale.

Why Penicillin Killed Some Bacteria but Not Others?

When Fleming preserved that contaminated plate and began testing the mold's properties, he noticed something puzzling — the mold didn't kill all bacteria equally.

The answer lies in cell wall structure differences between bacterial types. Gram-positive bacteria carry thick, exposed peptidoglycan layers that penicillin reaches easily. Gram-negative bacteria, however, wrap their thinner peptidoglycan in an outer lipopolysaccharide membrane, blocking penicillin's access entirely.

Once penicillin does penetrate, it works through penicillin binding protein inhibition — its beta-lactam ring mimics natural compounds that normally attach to transpeptidase enzymes. By locking onto these proteins irreversibly, penicillin stops peptidoglycan cross-linking fundamentally.

Without proper cross-linking, dividing bacteria can't build stable walls. Osmotic pressure then builds internally until cells rupture. You're observing bacteria destroy themselves during their own growth process. Some bacterial strains have developed resistance by producing beta-lactamase enzymes that break down penicillin's active ring before it can do any damage.

Importantly, penicillin's selective destruction of bacterial cells makes it a uniquely powerful treatment — human cells are unaffected because they lack the peptidoglycan cell walls that penicillin targets.

Why It Took a Decade for Penicillin to Matter?

Resource constraints crippled any real momentum. Laboratories lacked the industrial capacity to scale beyond experimental quantities, and the financial backing simply wasn't there.

The research environment worsened further when Florey and Chain's Oxford team faced personality clashes and methodological disputes that delayed progress by years.

It took three years of trial and error to crack purification, and ultimately, it wasn't scientific curiosity that drove urgency — it was World War II's demand for battlefield medicine that finally forced penicillin into the spotlight. In 1941, Albert Alexander became the first human patient treated with penicillin, yet supplies were so limited that his treatment could not be completed.

When Florey approached the MRC for funding in 1939, he received a modest sum that included £100 for expenses, underscoring just how underfunded the effort to develop one of medicine's greatest breakthroughs truly was.

How Fleming's Discovery Was Finally Turned Into Penicillin

Turning Fleming's raw discovery into a usable medicine required five key breakthroughs — improvised production, smarter fermentation, industrial scale-up, purification, and wartime urgency.

Oxford's team cultured mold in bedpans and bathtubs, producing 500 liters weekly. When fermentation scale up became critical, Norman Heatley joined Peoria's NRRL lab, where Andrew Moyer's switch to corn-steep liquor achieved tenfold yield increases.

Mary Hunt's cantaloupe mold strain multiplied output sixfold. Companies like Pfizer and Merck solved mass production challenges by engineering submerged fermentation tanks with aerating systems, anti-foaming agents, and advanced cooling technology.

Purification remained brutal — you'd lose two-thirds of penicillin during extraction — but freeze-drying finally produced a stable, sterile product. By 1945, Hunt's mold strain powered monthly production of 600 billion doses.

The First Patient Penicillin Ever Saved

The first human penicillin trial in 1941 didn't end in triumph — it ended in tragedy. Albert Alexander, a 43-year-old Oxford policeman, developed a severe infection from a small mouth sore, spreading to his face, eyes, and scalp. Doctors removed one eye just to relieve his pain.

On February 12, 1941, Charles Fletcher administered an initial trial dosage of 200 mg intravenously, followed by 100 mg every three hours. Alexander responded remarkably — his temperature dropped, wounds improved, and his remaining eye normalized within days.

Then penicillin shortage challenges derailed everything. The supply ran out after five days. Though the team recycled penicillin from Alexander's urine, it wasn't enough. He relapsed and died on March 15, 1941, but not before proving penicillin's extraordinary potential. Recognizing the need for wider access, Florey and Heatley traveled to America to push for industrial-scale penicillin production. By 1943, only 30 people in the United States had been treated with the life-saving drug.

Why Fleming Called His Own Penicillin Fame a Myth?

Albert Alexander's death — despite penicillin's undeniable promise — sealed Fleming's place in history as the man who'd discovered medicine's miracle drug. But Fleming himself recognized his excessive media fame wasn't entirely deserved.

It started with a 1942 Times article crediting Oxford for curing bacterial meningitis while omitting Florey and Chain entirely. Sir Almroth Wright then wrote to the Times suggesting Fleming deserved the laurels, redirecting public attention toward him.

Fleming spoke openly to journalists while Florey banned his Oxford team from press interviews, widening the gap further. The result? Florey and Chain's overlooked contributions — the actual development of penicillin as a usable medicine — faded from public memory. Fleming openly called this imbalance a myth, acknowledging the credit never told the full story. His 1929 publication in The British Journal of Experimental Pathology had introduced penicillin to the world, yet it was Florey and Chain who transformed it into the life-saving drug that would define the antibiotic era.

Fleming's Warning About Antibiotic Resistance Still Rings True

Fleming's fame may have overshadowed his colleagues, but his scientific instincts proved razor-sharp. As early as 1936, he warned medical students at Imperial College London that bacterial resistance would follow widespread antibiotic use — a prediction validated 86 years later.

His 1945 Nobel Lecture reinforced the long term significance of responsible dosing, cautioning that underdosage lets microbes survive and adapt. These warnings carry real medical ethics weight today.

WHO reports drug-resistant infections could kill 10 million annually by 2050. Up to 90% of those deaths will hit low-resource African and Asian countries. Misuse across humans, animals, and plants continues driving resistance.

Fleming didn't just discover penicillin — he foresaw exactly how humanity might squander it. He specifically cautioned that doctors would overuse antibiotics, a concern that has since become a defining crisis in modern medicine. His discovery came from a mould culture, a seemingly unremarkable observation that would go on to revolutionize medicine entirely.